Curanex Pharmaceuticals Inc Common Stock

CURXNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
0.30 USD
↘ 0.03 (8.73%)AT CLOSE (11:59 AM EDT)
0.32
↗ 0.02 (5.28%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
0.32
↗ 0.02 (5.28%)
🔴Market: CLOSED
Open?$0.32
High?$0.33
Low?$0.30
Prev. Close?$0.33
Volume?111.4K
Avg. Volume?95.3K
VWAP?$0.32
Rel. Volume?1.17x
Bid / Ask
Bid?$0.26 × 100
Ask?$0.37 × 100
Spread?$0.11
Midpoint?$0.31
Valuation & Ratios
Market Cap?8.5M
Shares Out?28.4M
Float?9.1M
Float %?32.2%
P/E Ratio?N/A
P/B Ratio?1.05
EPS?-$0.26
Dividend?0.00%
Ex-Dividend?N/A

Curanex Pharmaceuticals Inc Common Stock (CURX) is currently trading at $0.30. Technical indicators currently signal "Sell". This is driven by negative Return on Equity. Valuation metrics suggest CURX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Themes
Biotech - Drug Development›Metabolic & CardiometabolicBiotech - Drug Development›Immunology & Autoimmune
Employees
6
Market Cap
8.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.curanexpharma.com
Listed
2025-08-26
Address
2 JERICHO PLAZA,
JERICHO, NY 11753
Phone: 718-673-6078
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.41%Low
Short Interest?37.3K
Days to Cover?1.0
Free Float9.1M
Avg Daily Volume145.3K
Settlement Date2026-05-15
Financial Health
Current Ratio?62.87Strong
Quick Ratio?62.87Strong
Cash Ratio?31.22Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
1.05CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-89.6%WEAK▾
ROA?
S&P
3
-86.1%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$4.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist